Haussermann P, Kuhn W, Przuntek H, Muller T
Department of Neurology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Neurosci Lett. 2001 Mar 16;300(3):182-4. doi: 10.1016/s0304-3940(01)01574-9.
Dysfunction of the blood-cerebrospinal fluid barrier (BCB) has been implicated in the pathogenesis of Parkinson's disease (PD) and other neurodegenerative disorders. Therefore, we assayed serum and cerebrospinal fluid (CSF) from 30 parkinsonian patients and 30 controls for concentrations of albumin and IgG. The CSF/serum ratio for albumin (AQ), IgG (GQ), IgG-index as well as determination of oligoclonal bands were used to evaluate BCB function and to quantify humoral immune response within the central nervous system (CNS). Levels of AQ, GQ and IgG-index did not significantly differ in both groups. We found no dysfunction of the blood-CSF barrier or signs of local synthesis of IgG in the central nervous system of parkinsonian patients. Our data do not support the hypothesis of a dysfunctional BCB that contributes to pathophysiological mechanisms underlying PD.
血脑脊髓液屏障(BCB)功能障碍与帕金森病(PD)及其他神经退行性疾病的发病机制有关。因此,我们检测了30例帕金森病患者和30例对照者血清和脑脊液(CSF)中白蛋白和IgG的浓度。采用白蛋白脑脊液/血清比值(AQ)、IgG脑脊液/血清比值(GQ)、IgG指数以及寡克隆带的检测来评估BCB功能,并量化中枢神经系统(CNS)内的体液免疫反应。两组患者的AQ、GQ和IgG指数水平无显著差异。我们未发现帕金森病患者中枢神经系统存在血脑脊液屏障功能障碍或IgG局部合成的迹象。我们的数据不支持功能失调的BCB促成PD潜在病理生理机制的假说。